Saturday, July 12, 2025
spot_img

India’s first intranasal vaccine for COVID gets DCGI approval

Date:

Share post:

spot_imgspot_img

New Delhi, Sep 6:  India’s first intranasal Covid vaccine by Bharat Biotech on Tuesday got the approval from the Drug Controller General of India for 18+ age group for restricted use in emergency situation.

Announcing the achievements, Union Health Minister Mansukh Mandaviya termed it a ‘big boost to India’s fight against Covid-19.

“Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation,” Mandaviya tweeted.

In the subsequent tweet he said, “This step will further strengthen our collective fight against the pandemic.

“India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji’s leadership. With the science-driven approach & Sabka Prayas, we will defeat COVID-19”, he said.

IANS
spot_imgspot_img

Related articles

DRDO and IAF successfully test Astra BVRAAM with indigenous radio frequency seeker from Su-30 Mk-I

New Delhi, July 11: In a significant boost to India's self-reliance in defence technology, the Defence Research and...

Mayank Yadav’s rehab likely to start in coming weeks after undergoing surgery in Christchurch

New Delhi, July 11: Tearaway fast bowler Mayank Yadav is likely to begin his long rehab in the...

Pakistan: 98 killed, 185 injured as monsoon rains wreak havoc

Islamabad, July 11: Torrential monsoon rains and flash floods have claimed at least 98 lives and left 185...

India’s purchase of Russian oil helped bring down global prices: Hardeep Puri

New Delhi, July 11: Minister of Petroleum and Natural Gas Hardeep Singh Puri said on Friday that India’s...